Highlights of the American thyroid association guidelines for patients with thyroid nodules or differentiated thyroid carcinoma: The 2009 revision

Thyroid

Volumn 19, Issue 11, 2009, Pages 1139-1143

  Wartofsky, Leonard ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT THYROTROPIN;

ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; CYTOLOGY; EDITORIAL; HUMAN; MEDICAL PRACTICE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; THYROID CANCER; THYROID CARCINOMA; THYROID NODULE; THYROIDECTOMY;

HUMANS; THYROID GLAND; THYROID NEOPLASMS;

EID: 70449387269     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.1599     Document Type: Editorial

References (34)

1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16: 109-142.
2. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
3. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr 2009 Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565-612.
4. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803.
5. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, Tennvall J, Bombardieri E 2008 Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35:1941-1959.
6. British Thyroid Association and Royal College of Physicians 2007 Guidelines for the management of thyroid cancer, 2nd edition. Available at www.british-thyroid-association.org= news=Docs=Thyroid-cancer-guidelines-2007. pdf. Accessed September 20, 2009.
7. Watkinson JC 2004 The British Thyroid Association guidelines for the management of thyroid cancer in adults. Nucl Med Commun 25:897-900.
8. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ 2009 Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
9. Davies L, WelchHG2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
10. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS 2009 Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 18: 784-791.
11. Rego-Iraeta A, Perez-Mendez LF, Mantinan B, Garcia-Mayor RV 2009 Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 19:333-340.
12. Chen AY, Jemal A, Ward EM 2009 Increasing incidence of differentiated thyroid cancer in the United States 1988-2005. Cancer 115:3801-3807.
13. Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA 2008 Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost effectiveness and decision analysis. J Clin Endocrinol Metab 93:2173-2180.
14. Rink T, Truong P-N, Schroth H-J, Diener J, Zimny M, Grunwald F 2009 Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19:327-332.
15. Abraham D, Gault PM, Hunt J, Bentz J 2009 Calcitonin estimation in neck lymph node fine-needle aspirate fluid prevents misinterpretation of cytology in patients with metastatic medullary thyroid cancer. Thyroid 19:1015-1016.
16. Boi F, Maurelli I, Pinna G, Atzeni F, Piga M, Lai ML, Mariotti S 2007 Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J Clin Endocrinol Metab 92:2115-2118.
17. Mazzaferri EL, Sipos J 2008 Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and preoperative neck ultrasonography to define the extent of tumor invasion? Thyroid 18:597-602.
18. Xing M, Clark DP, Guan H, Ji M, Dackiw APB, Carson KA, Kim M, Tufaro AP, Ladenson PW, Zeiger MA, Tufano RP 2009 BRAF mutation testing of thyroid fine needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 27:2977-2982.
19. Bentz BG, Miller BT, Holden JA, Rowe LR, Bentz JS 2009 B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules. Otolaryngol Head Neck Surg 140:708-714.
20. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098.
21. American Joint Committee on Cancer 2002. Cancer Staging Manual, 6th edition. Springer-Verlag, New York
22. Ross DS, Litofsky D, Ain KB, Bigos T, Brierley JD, Cooper DS, Haugen BR, Jonklaas J, Ladenson PW, Magner J, Robbins J, Skarulis MC, Steward DL, Maxon HR, Sherman SI 2009 Recurrence after treatment of micropapillary thyroid cancer. Thyroid 19:1043-1048.
23. Pilli T, Brianzoni E, Capoccetti F, Castagna MG, Fattori S, Poggiu A, Rossi G, Ferretti F, Guarino E, Burroni L, Vattimo A, Cipri C, Pacini F 2007 A comparison of 1850 (50 mCi) and 3700MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer. J Clin Endocrinol Metab 92:3542-3546.
24. Rosario PW, Borges MA, Purisch S 2008 Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity. J Nucl Med 49:1776-1782.
25. Remy H, Borget I, Leboulleux S, Guilabert N, Lavielle F, Garsi J, Bournaud C, Gupta S, Schlumberger M, Ricard M 2008 131I effective half-life and dosimetry in thyroid cancer patients. J Nucl Med 49:1445-1450.
26. Van Nostrand D, Aiken M, Atkins F, Moreau S, Garcia C, Acio E, Burman K, Wartofsky L 2009 The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer. Thyroid 19:849-1585
27. McDougall IR 2009 The case for obtaining a diagnostic whole-body scan prior to Iodine 131 treatment of differentiated thyroid cancer. Thyroid 19:811-813.
28. Shakir MK, Krook LS, Schraml FV, Hays JH, Clyde PW 2008 Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma. Thyroid 18:787-792.
29. Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID 1998 The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 83:4195-4203.
30. Kulkarni K, Nostrand DV, Atkins F, Aiken M, Burman K, Wartofsky L 2006 The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer. Thyroid 16:1019-1023.
31. Tuttle RM, Leboeuf R, Robbins RJ, Qualey R, Pentlow K, Larson SM, Chan CY 2006 Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer. J Nucl Med 47:1587-1591.
32. Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S 2005 Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med 46: 261-266.
33. Van Nostrand D, Atkins F, Bandaru VV, Chennupati SP, Moreau S, Burman K, Wartofsky L 2009 Salivary gland protection with sialagogues: a case study. Thyroid 19: 1005-1008.
34. Kloos RT 2009 Protecting thyroid cancer patients from untoward effects of radioactive iodine treatment. Thyroid 19:925-928.